Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

174.260
+2.6901.57%
Volume:1.41M
Turnover:244.80M
Market Cap:83.46B
PE:-23.21
High:174.300
Open:172.800
Low:171.290
Close:171.570
52wk High:216.734
52wk Low:88.830
Shares:478.91M
Float Shares:478.91M
Volume Ratio:1.36
T/O Rate:0.29%
Dividend:4.10
Dividend Rate:2.35%
EPS(TTM):-7.508
EPS(LYR):-7.508
ROE:-15.83%
ROA:7.26%
PB:4.02
PE(LYR):-23.21

Loading ...

Company Profile

Company Name:
CSL LIMITED
Exchange:
ASX
Establishment Date:
1916
Employees:
29000
Office Location:
655 Elizabeth Street,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9389 1434
Introduction:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.